Clinical Trial: Clinical Research Cohort for Polycystic Ovary Syndrome

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739940) titled 'Clinical Research Cohort for Polycystic Ovary Syndrome' on July 28.

Brief Summary: Polycystic Ovary Syndrome (PCOS) is a multifactorial metabolic-endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. According to the 2023 International Evidence-based Guidelines for the Assessment and Management of PCOS, its global prevalence ranges from 10% to 13%, making it one of the major diseases affecting women's health across the entire lifespan. The clinical manifestations of PCOS are highly heterogeneous, leading to menstrual disturbances (such as amenorrhea and abnormal uterine bleedi...